by Stacey Johnson | Aug 4, 2017
Engaging with the media is not for the faint of heart, but speaking on behalf of the entire world, we need you to step up scientists! Your research is important and valuable, and you may (I chose that word deliberately) be the best person to communicate it. So, while...
by Stacey Johnson | Jul 27, 2017
Last August, Signals hosted its first blog carnival and it was so much fun, we’re doing it again. Missed it? No idea what a blog carnival involves? The way I explained it last year is like this: A blog carnival is essentially an online blogging “party” with many...
by Stacey Johnson | Jul 14, 2017
I’ve been thinking about unapproved stem cell treatments a lot recently. First, I read this article that hailed the arrival of stem cell treatments in a small community in western Canada. There were many statements in the article that concerned me, but I only...
by Jovana Drinjakovic | May 10, 2017
Last month, a study published in Nature revealed that researchers have unknowingly been working on human stem cell lines that harbour mutations in a gene linked to many cancers, raising safety concerns over their use in therapy. But the findings don’t condemn stem...
by Stacey Johnson | Apr 21, 2017
3D printing is a topic we’ve covered before at Signals. It’s still hot and trendy, and still making the cut on top technology lists. Back in 2012, Chris Anderson, the former editor-in-chief of Wired, predicted that 3D printing “will be bigger than the web.”...
by David Kent | Apr 18, 2017
With the Toronto Blue Jays* off to a terrible start, I was almost dissuaded from reading anything about baseball, until I happened upon the following article: “Stem-cell therapy is poised to disrupt the Tommy John epidemic in baseball.” First, I had to do my standard...
Comments